Skip to main content

letter

. 1978 Aug 19;2(6136):563. doi: 10.1136/bmj.2.6136.563

Drugs for myeloma.

J S Malpas, D Parker

PMCID: PMC1607016 PMID: 698569

563

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Alexanian R., Salmon S., Bonnet J., Gehan E., Haut A., Weick J. Combination therapy for multiple myeloma. Cancer. 1977 Dec;40(6):2765–2771. doi: 10.1002/1097-0142(197712)40:6<2765::aid-cncr2820400602>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
Case D. C., Jr, Lee D. J., 3rd, Clarkson B. D. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. Am J Med. 1977 Dec;63(6):897–903. doi: 10.1016/0002-9343(77)90543-5. [DOI] [PubMed] [Google Scholar]
Durie B. G., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975 Sep;36(3):842–854. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES